Nickel allergy in interatrial shunt device-based closure patients

Congenital Heart Disease

Volumn 2, Issue 6, 2007, Pages 416-420

  Rigatelli, Gianluca ^a,b   Cardaioli, Paolo ^a   Giordan, Massimo ^a   Aggio, Silvio ^a   Chinaglia, Mauro ^a   Braggion, Gabriele ^a   Roncon, Loris ^a  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b Transcranial Doppler Ultrasound Service ^*  (Italy)

Author keywords

Allergy; Congenital Heart Disease; Device

Indexed keywords

ANTIARRHYTHMIC AGENT; CLOPIDOGREL; NITINOL; PREDNISONE;

ADULT; ARTICLE; ASTHENIA; CLINICAL ARTICLE; DISEASE DURATION; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; INCIDENCE; LABORATORY TEST; LEUKOCYTOSIS; MALE; NICKEL HYPERSENSITIVITY; OUTCOME ASSESSMENT; PATCH TEST; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL APPROACH; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALLOYS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; NICKEL; PROSPECTIVE STUDIES; SKIN TESTS; STENTS; TIME FACTORS;

EID: 36348952103     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2007.00134.x     Document Type: Article

References (17)

1. Marks JR, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group path-test results, 1998-2000. Am J Contact Dermatol. 2003;14:59-62.
2. Fukahara K, Minami K, Reiss N, et al. Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg. 2003;125:213-214.
3. Lai DW, Saver JL, Araujo JA, et al. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: A case report. Catheter Cardiovasc Interv. 2005;66:424-426.
4. Wertman B, Azarbal B, Riedl M, et al. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol. 2006;47:1226-1227.
5. Ale SI, Maibach HI. Reproducibility of patch test results: A concurrent right-versus-left study using TRUE test. Contact Derm. 2004;50:304-312.
6. Lang RM, Bierig M, Devereux RB, et al.; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
7. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology. 1999;52:1622-1625.
8. Zanchetta M, Rigatelli G, Pedon L, et al. Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Int J Cardiovasc Imaging. 2005;21:391-401.
9. Boutin C, Musewe NN, Smallhorn JF, et al. Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation. 1993;88:621-627.
10. Kong H, Wilkinson JL, Coe JY, et al. Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young. 2002;12:260-265.
11. Ries MW, Kampmann C, Rupprecht HJ, et al. Nickel release after implantation of the Amplatzer occluder. Am Heart J. 2003;145:737-741.
12. Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart. 2007;93:444-449.
13. Burian M, Neumann T, Weber M, et al. Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: A study in patients with atrial septal defects implanted with an Amplatzer occluder. Int J Clin Pharmacol Ther. 2006;44:107-112.
14. Arquizan C, Touze E, Moulin T, et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Blood pressure, smoking and oral contraceptive control after cryptogenic stroke in young adults in the PFO-ASA Study. Cerebrovasc Dis. 2005;20:41-45.
15. Sastry S, Riding G, Morris J, et al. Young adult myocardial infarction ischemic stroke role paradox embolism thrombophilia (the YAMIS Study). J Am Coll Cardiol. 2006;48:686-691.
16. Schwerzmann M, Windecker S, Wahl A. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart. 2004;90:186-190.
17. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol. 2006;48:161-169.